The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs cut its rating on the stock to Neutral from Buy.

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Morgan Stanley from $70.00 to $38.00 in a report issued on Wednesday,Benzinga reports. Morgan Stanley currently has an equal ...

The funding will accelerate the development of an H5N1 mRNA influenza vaccine, which is well-matched to strains currently circulating in cows and birds, and expand clinical data supporting the use ...

The U.S. government previously awarded the vaccine manufacturer $176 million in July 2024 to help expedite the development of an mRNA vaccine that could be used for bird flu. mRNA technology is ...

WASHINGTON - US President Joe Biden’s outgoing administration on Jan 16 announced US$211 million (S$288.4 million) in new funding to develop mRNA vaccines against emerging bio threats and said ...